The short answer
A peptide is a short chain of amino acids.
Amino acids are the small molecules the body uses as building blocks. String a few of them together and the result is a peptide. String hundreds or thousands together and the result is a protein. The chemistry is the same; the difference is length — and where exactly length turns one word into the other depends on who is counting, as the 40-amino-acid rule in US drug law shows.
That is genuinely the whole definition. Everything else written about peptides — what they do, whether they are safe, whether they are legal — depends entirely on which peptide, and not at all on the word itself.
Why the word is confusing
The word gets used for three different things at once, and they are routinely mixed together:
Peptides your body already makes. Insulin, oxytocin, and the hormones that tell the pituitary gland when to release growth hormone are all peptides (growth hormone itself, somatropin, is a protein). They are not exotic; they are ordinary biology. The three-amino-acid antioxidant every cell makes for itself is one of the most-researched molecules in science and still has no approved injectable product — a reminder that being made by the body is not by itself a reason to inject more of it.
Peptides approved as medicines. Insulin has been an approved medicine for about a century. Tesamorelin was approved in the United States in 2010 for a narrow, specific use. Bremelanotide was approved in 2019 for another. These are prescription drugs with labels, warnings and known side effects.
Peptides sold as research chemicals. This is the large group, and the one most online writing is actually about — BPC-157, TB-500, ipamorelin, epitalon and dozens more. These are not approved for human use anywhere. What is sold carries a "research use only" label, which describes what the seller says the product is for. It is not a safety finding, and no regulator evaluated the substance because that label is on the bottle.
A page that uses the word "peptide" across all three groups without saying which one it means is doing something misleading, whether or not it intends to. Insulin's hundred-year safety record has nothing to do with a compound synthesised last year and sold in a vial. How the library's 107 entries split between measured benefit and no human record at all is counted on whether peptides are good for you, or safe.
How to read a claim about a peptide
Most claims fall apart on one question: shown in what?
Almost every dramatic statement about the research compounds traces back to studies in rats or mice. Those studies are real science and worth reading. They are also not evidence about people. Doses do not translate directly, animal biology differs in ways that matter, and the historical record is blunt: most compounds that work in animals do not go on to work in humans.
So the useful reading habit is simple. When a page says a compound "accelerates healing" or "improves recovery", look for the species. If the page does not tell you, that omission is itself information.
Every entry in this library states, in the first paragraph, how much of the evidence behind a compound is human and how much is not. The full index of compound entries lists them alphabetically with the status of each.
Where a compound stands with regulators
There are several different statuses, and they are often confused with one another:
Approved medicine. A regulator has reviewed the evidence and approved the substance for a stated use, with a label that sets out doses, warnings and contraindications. Tesamorelin and bremelanotide are examples.
Unapproved. No regulator has approved it for anything. This covers most compounds in this library.
Restricted in compounding. In the United States, the FDA maintains a list of bulk substances it considers to raise significant safety risks when a pharmacy compounds them into preparations. As of that page's most recent update, 2026-04-22, it names ipamorelin acetate, kisspeptin-10, GHRP-2 and GHRP-6, each added on 2023-09-29. This is a specific, narrow restriction on pharmacy compounding — not a general finding about a substance, and not the same thing as a ban.
Being absent from that list means nothing in itself. Several compounds are absent because their nominations were withdrawn before a decision, which is not the same as being cleared.
Two companion pages sit alongside this one: the chemistry of the link itself, and an index of every compound here grouped by purpose.
How this library is organised
One entry per compound. Every entry answers the same questions in the same order: what it is, what it is said to be good for, what the research actually shows, where it stands with regulators, and when the entry was last checked.
Terms are explained where they appear. Nothing here recommends taking anything, and nothing here ranks products or sellers.
Underneath the compound entries sits the chemistry they all rest on: the twenty building blocks and what each one weighs, which is enough to check a vendor's stated molecular weight against a published sequence, and how those blocks are strung together into a chain, where a count across this library's own entries puts the median compound at ten residues. And at the other end of the word's range sits the connecting peptide measured in blood tests — a 31-residue chain nobody sells, which shows how little the word "peptide" commits anyone to. The heart hormone reported as BNP makes the point again from a different direction.